Core Viewpoint - ST Pava (688184.SH) is forecasting a net loss for the year 2025, with expected losses ranging from 700 million to 550 million yuan, indicating a reduction in losses compared to the previous year [1] Financial Performance - The company anticipates a net profit attributable to shareholders of the parent company for 2025 to be between -700 million and -550 million yuan, which represents a reduction in losses of 26.5 million to 176.5 million yuan, or a year-on-year decrease of 3.65% to 24.29% [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between -695 million and -545 million yuan, reflecting a reduction in losses of 36.76 million to 186.76 million yuan, or a year-on-year decrease of 5.02% to 25.52% [1] - In 2023 and 2024, the company reported revenues of 954 million yuan and 949 million yuan, with net losses attributable to shareholders of -248 million yuan and -727 million yuan, respectively [4] Audit and Compliance - Tianjian Accounting Firm issued a negative opinion on the internal control of the company's 2024 financial report, and the internal control audit for 2025 is still in progress, presenting uncertainties [1] - There is a risk that if the 2025 financial report receives an audit report with a disclaimer or negative opinion, the company's stock may face delisting risk warnings from the Shanghai Stock Exchange [1] Company Background - ST Pava was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 19, 2022, with an initial public offering of 33,594,557 shares at a price of 51.88 yuan per share [2] - The total funds raised from the IPO amounted to approximately 1.74 billion yuan, with a net amount of about 1.60 billion yuan after deducting issuance costs [3]
破发股ST帕瓦连亏三年 2022年上市即巅峰募17亿元